GE Healthcare SenoClaire 3D Breast Tomosynthesis - Manual (Page 3)

© 2013 Copyright GE Healthcare - HCS DGS WH BC 06 16 1 DOC1407652
GE imagination at work
Data subject to change.
Marketing Communications GE Medical Systems
Société en Commandite Simple au capital de de 85.418.040 Euros
283 rue de la Minière – 78533 Buc Cedex France
RCS Versailles B 315 013 359
A General Electric company, doing business as GE Healthcare
SenoClaire is also available on Senographe Care
*GE, GE monogram, Senographe, SenoClaire and ASiR,
are trademarks of General Electric Company.
It’s a requirement of dose performance that patient X-ray dose
be kept as low as reasonably acceptable. A single MLO view of
SenoClaire, powered by ASiR
DBT , provides clinical non-inferiority
when compared to 2-view digital mammography. It’s half the dose,
with one single compression.
Powered by SenoClaire technology:
• SenoClaire’s ASiR DBT iterative reconstruction algorithm delivers
FFDM-like images and positively impacts microcalcification
conspicuity versus the traditional Filtered Back Projection (FBP)
algorithm.
• SenoClaire’s 3D MLO sequence requires only nine exposures
with an even distribution of the dose.
• The SenoClaire grid in 3D reduces scattered radiation and
improves detectability in 3D for breasts of above-average
thickness,
while preserving dose and performance.
• The dual-track X-ray tube (Mo/Rh) delivers optimal X-ray spectra
to penetrate the breast based on breast density and compressed
breast thickness. Automatic Optimization of Parameters (AOP)
helps you identify the densest breast regions and automatically
selects the appropriate anode, filter, kV and mAs to ensure
repeatable image quality at optimized radiation dose.
L E S S D O S E